FB2024_03 , released June 25, 2024
Allele: Dmel\ATP7GD3322
Open Close
General Information
Symbol
Dmel\ATP7GD3322
Species
D. melanogaster
Name
FlyBase ID
FBal0198609
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Also Known As
ATP7RNAi, UAS-ATP7RNAi
Key Links
Genomic Maps

Transgenic product class
Nature of the Allele
Transgenic product class
Progenitor genotype
Carried in construct
Cytology
Description

UASt regulatory sequences drive expression of an inverted repeat.

Allele components
Component
Use(s)
Encoded product / tool
Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 0 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 1 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Expression of ATP7GD3322 driven in the thoracic midline by Scer\GAL4pnr-MD237 causes a hypo-pigmentation phenotype in the adult thorax and abdomen, compared to controls.

Expression of ATP7GD3322 driven by Scer\GAL4elav-C155 does not significantly affect larval lethality compared to controls.

Expression of ATP7GD3322 under the control of Scer\GAL4pnr-MD237 results in a strong hypopigmentation phenotype in the adult dorsal cuticle of the thorax and abdomen (in the domain of Scer\GAL4 expression).

Expression of ATP7GD3322 under the control of Scer\GAL4GMR.PFa has no effect on the eye.

Adults expressing ATP7GD3322 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.

Expression under the control of Scer\GAL4pnr-MD237 results in a colour difference between the central Scer\GAL4pnr-MD237 expression domain of the notum and the surrounding lateral region in 100% of the Scer\GAL4pnr-MD237 expression domain.

Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 100% of the Scer\GAL4pnr-MD237 expression domain.

External Data
Bristle Screen Database (Knoblich Lab) - A database for RNAi phenotypes in bristle and notum development
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
NOT Enhanced by
NOT suppressed by
Enhancer of
NOT Enhancer of
NOT Suppressor of
Other
Phenotype Manifest In
Additional Comments
Genetic Interactions
Statement
Reference

Co-expression of ATP7GD3322 along with Grx1GD10587 driven in the thoracic midline by Scer\GAL4pnr-MD237 results in an additive phenotype, with both thoracic cleft and hypo-pigmentation visible in the adult.

Co-expression of ATP7GD3322 does not significantly enhance larval lethality seen with expression of GclcGD9767 driven by Scer\GAL4elav-C155.

Co-expression of PhmKK112513 and ATP7GD3322 under the control of Scer\GAL4elav-C155 does not result in any obvious phenotype, as compared to controls.

Co-expression of ATP7GD3322 has no effect on the eye phenotype caused by expression of Ctr1AGD16726 under the control of Scer\GAL4GMR.PFa.

Co-expression of Ctr1BScer\UAS.T:Zzzz\FLAG and ATP7GD3322 under the control of Scer\GAL4GMR.PFa results in male lethality, while females have a severe rough eye phenotype together with loss of eye pigmentation.

Co-expression of Ctr1AScer\UAS.T:Zzzz\FLAG and ATP7GD3322 under the control of Scer\GAL4GMR.PFa results in male lethality, while females have a severe rough eye phenotype.

Xenogenetic Interactions
Statement
Reference

Co-expression of ATP7GD3322 enhances the mobility defects of flies expressing Hsap\HTTQ93.ex1p.Scer\UAS under the control of Scer\GAL4elav.PU.

Co-expression of ATP7GD3322 enhances loss of eye pigmentation and progressive loss of rhabdomeres seen in flies expressing Hsap\HTTQ93.ex1p.Scer\UAS under the control of Scer\GAL4GMR.PU.

Co-expression of ATP7GD3322 enhances the aggregation of Hsap\HTTQ93.ex1p.Scer\UAS protein seen in the brains of flies expressing Hsap\HTTQ93.ex1p.Scer\UAS under the control of Scer\GAL4elav.PU.

Co-expression of ATP7GD3322 has no effect on the reduction in lifespan seen in flies expressing Hsap\HTTM8V.H82A.Q127.ex1p.Scer\UAS under the control of Scer\GAL4elav.PU at 29[o]C.

Co-expression of ATP7GD3322 has no effect on the mobility defects seen in flies expressing Hsap\HTTM8V.H82A.Q127.ex1p.Scer\UAS under the control of Scer\GAL4elav.PU at 29[o]C.

Co-expression of ATP7GD3322 has no effect on the loss of eye pigmentation seen in flies expressing Hsap\HTTM8V.H82A.Q127.ex1p.Scer\UAS under the control of Scer\GAL4GMR.PU at 29[o]C.

Complementation and Rescue Data
Comments

Co-expression of ATP7Scer\UAS.T:Zzzz\FLAG rescues the cuticle hypopigmentation phenotype caused by expression of ATP7GD3322 under the control of Scer\GAL4pnr-MD237.

Images (0)
Mutant
Wild-type
Stocks (1)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 1 )
Linkouts
Bristle Screen Database (Knoblich Lab) - A database for RNAi phenotypes in bristle and notum development
Synonyms and Secondary IDs (1)
Reported As
Symbol Synonym
ATP7GD3322
Name Synonyms
Secondary FlyBase IDs
    References (14)